Blame capitalism? Why hundreds of decades-old yet vital drugs are nearly impossible to find
Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
Jul 20, 2023
0
0
Past public ire over high drug prices has recently taken a back seat to a more insidious problem—no drugs at any price.
Jul 20, 2023
0
0
Generic prescription drugs have saved the U.S. about US$1.7 trillion over the past decade. The Food and Drug Administration approved a record 781 new generics in 2018 alone, including generic versions of Cialis, Levitra ...
Dec 4, 2019
0
2
Researchers from three universities have found that extreme price competition in the generic pharmaceutical market—designed to make medications more affordable—may be putting more patients at serious health risk, as evidenced ...
May 30, 2018
0
3
Drug manufacturing and pricing vaulted into the news several years ago when a privately held company raised the price of a drug used for infections from US$13.50 to $750 for one pill.
Mar 28, 2018
0
2
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in the retail sector, ...
Jan 21, 2015
0
13
Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday.
Jun 24, 2013
0
0
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Apr 16, 2013
1
0
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Apr 10, 2013
0
0
(AP)—The Supreme Court will decide whether generic drug manufacturers can be held responsible in state courts for possible design defects that are in the brand-name medicine they are copying.
Nov 30, 2012
0
0
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Mar 12, 2012
0
1